Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union Read more about Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union
Array BioPharma and Amgen Partner in Type 2 Diabetes Read more about Array BioPharma and Amgen Partner in Type 2 Diabetes
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care Read more about Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
NEW STUDY RESULTS PRESENTED AT 2009 SAN ANTONIO BREAST CANCER SYMPOSIUM SHOW IMPORTANCE OF PROTECTING YOUR BONES Read more about NEW STUDY RESULTS PRESENTED AT 2009 SAN ANTONIO BREAST CANCER SYMPOSIUM SHOW IMPORTANCE OF PROTECTING YOUR BONES
Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP Read more about Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program Read more about Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Nplate(R) Data From MDS Studies Presented at ASH Read more about Nplate(R) Data From MDS Studies Presented at ASH
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists Read more about New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen Highlights Data to be Presented at ASH Read more about Amgen Highlights Data to be Presented at ASH
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards Read more about Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
